Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

 1,868.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 2,568.00
  • 52 Week Low: 1,637.00
  • Currency: UK Pounds
  • Shares Issued: 66.03m
  • Volume: 0
  • Market Cap: £1,233.49m
  • RiskGrade: 128

Genus promotes FD Stephen Wilson to role of CEO

By Iain Gilbert

Date: Thursday 22 Aug 2019

LONDON (ShareCast) - (Sharecast News) - Animal genetics company Genus has promoted group finance director Stephen Wilson to the role of chief executive.
Wilson will take over from outgoing CEO Karim Bitar, who is leaving to head up another company, on 13 September.

Having joined Genus in January 2013, Wilson already had "a very strong and deep understanding" of the group and had been an integral part of the strategic and operational development of the company, as it continued to grow and strengthen its position as a world leader in animal genetics, the company said.

The FTSE 250 business said Wilson was "by far the strongest candidate for the role" following a review of both external and internal candidates.

The search for a permanent replacement for the role of FD is already underway, with financial controller Janet Duane taking over on an interim basis.

Chairman Bob Lawson said: "Stephen has already had significant strategic and operational input in the development of Genus and no one knows the business better than him. We are delighted that Stephen will drive Genus through the next stage of our continued growth, and it is clear that Genus is, and will continue to be, in strong hands."

As of 0840 BST, Genus shares had ticked up 0.15% to 2,602p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 1,868.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 2,568.00
52 Week Low 1,637.00
Volume 0
Shares Issued 66.03m
Market Cap £1,233.49m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
96.04% below the market average96.04% below the market average96.04% below the market average96.04% below the market average96.04% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
53.64% below the market average53.64% below the market average53.64% below the market average53.64% below the market average53.64% below the market average
18.52% above the sector average18.52% above the sector average18.52% above the sector average18.52% above the sector average18.52% above the sector average
Income
86.4% below the market average86.4% below the market average86.4% below the market average86.4% below the market average86.4% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Growth
67.9% below the market average67.9% below the market average67.9% below the market average67.9% below the market average67.9% below the market average
64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 29-Feb-24 09-Nov-23
Paid 28-Mar-24 08-Dec-23
Amount 10.30p 21.70p

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

Genus Key Personnel

CFO Alison Henriksen
CEO Jorgen Kokke

Top of Page